Successful Treatment of Antiepileptic Drug-Induced DRESS Syndrome with Pulse Methylprednisolone
Author(s) -
Çelebi Kocaoğlu,
Ceyda Cilasun,
Ece Selma Solak,
Gülcan Saylam Kurtipek,
Şükrü Arslan
Publication year - 2013
Publication title -
case reports in pediatrics
Language(s) - English
Resource type - Journals
eISSN - 2090-6803
pISSN - 2090-6811
DOI - 10.1155/2013/928910
Subject(s) - medicine , lamotrigine , carbamazepine , valproic acid , methylprednisolone , rash , dermatology , drug , eosinophilia , gabapentin , antiepileptic drug , anticonvulsant , epilepsy , anesthesia , pharmacology , psychiatry , pathology , alternative medicine
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but potentially life-threatening syndrome characterized by skin rash, fever, lymph node enlargement, and involvement of internal organs. It is most commonly induced by aromatic anticonvulsants and antibiotics. Nonaromatic anticonvulsants are rarely encountered as the causes of DRESS syndrome. In the present report, three discrete cases with DRESS syndrome developing due to three antiepileptic drugs, including valproic acid (nonaromatic), carbamazepine (aromatic), and lamotrigine (aromatic), and their treatment modalities were aimed to be discussed in light of the literature. To the best of our knowledge, our cases are the first children to be treated with pulse methylprednisolone in the literature.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom